Gemfibrozil in dyslipidaemia. 1990

S C Kundu, and S Roxy, and S K Batabyal
Dept. of Biochemistry, B.R. Singh Hosp., Calcutta.

A new lipid regulating agent, Gemfibrozil was evaluated in different types of dyslipidaemias. Out of a total of 34 patients, all completed 12 weeks' treatment and 26 completed 24 weeks' of treatment. A significant reduction in total cholesterol, LDL-c triglyceride and apo-B and an increase in HDL cholesterol and its apoprotein--apo-A were observed. The patients belonged to hyperlipidaemias--types IIa, IIb, and IV. Patients' compliance was good and side effects were minimal.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

S C Kundu, and S Roxy, and S K Batabyal
January 1982, Acta medica Scandinavica. Supplementum,
S C Kundu, and S Roxy, and S K Batabyal
January 1982, Acta medica Scandinavica. Supplementum,
S C Kundu, and S Roxy, and S K Batabyal
January 1996, IARC monographs on the evaluation of carcinogenic risks to humans,
S C Kundu, and S Roxy, and S K Batabyal
February 2016, Nature reviews. Cardiology,
S C Kundu, and S Roxy, and S K Batabyal
March 2017, Nature reviews. Cardiology,
S C Kundu, and S Roxy, and S K Batabyal
August 2003, Lancet (London, England),
S C Kundu, and S Roxy, and S K Batabyal
August 2014, Lancet (London, England),
S C Kundu, and S Roxy, and S K Batabyal
June 2006, Clinical evidence,
Copied contents to your clipboard!